Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Journal of Molecular Medicine (Berlin, Germany)
|
November 26, 2005
cIAP2 is highly expressed in Hodgkin-Reed-Sternberg cells and inhibits apoptosis by interfering with constitutively active caspase-3
Horst Dürkop, Burkhard Hirsch, Corinna Hahn, et al.
Leukemia & Lymphoma
|
June 20, 2007
New anti-CD30 human pancreatic ribonuclease-based immunotoxin reveals strong and specific cytotoxicity in vivo
Sandra Braschoss, Burkhard Hirsch, Stefan Dübel, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 12, 2011
Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells
Osamu Suzuki, Burkhard Hirsch, Masafumi Abe, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 3, 2013
RIP1 expression is necessary for CD30-mediated cell death induction in anaplastic large-cell lymphoma cells
Burkhard Hirsch, Edda von der Wall, Michael Hummel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 4, 2011
Retraction: The IL-15Rα chain signals through association with Syk in human B cells
Thomas Pohl, Hans Krause, Horst Dürkop, et al.
The Journal of Pathology
|
May 20, 2003
Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation
Horst Dürkop, Burkhard Hirsch, Corinna Hahn, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 9, 2007
A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice
Hendrik Fuchs, Christopher Bachran, Tongyu Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2008
Epstein-Barr virus associated large B-cell cardiac lymphoma with simultaneous manifestation in the forearm
Naser Qedra, Chalid Assaf, Horst Dürkop, et al.
Molecular Oncology
|
July 30, 2017
Targeted dianthin is a powerful toxin to treat pancreatic carcinoma when applied in combination with the glycosylated triterpene SO1861
Cheenu Bhargava, Horst Dürkop, Xiangli Zhao, et al.
Journal of Cancer Research and Clinical Oncology
|
January 13, 2018
Antibody-based delivery of tumor necrosis factor (L19-TNFα) and interleukin-2 (L19-IL2) to tumor-associated blood vessels has potent immunological and anticancer activity in the syngeneic J558L BALB/c myeloma model
Hans D Menssen, Ulf Harnack, Ulrike Erben, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Journal of Molecular Medicine (Berlin, Germany)
|
November 26, 2005
cIAP2 is highly expressed in Hodgkin-Reed-Sternberg cells and inhibits apoptosis by interfering with constitutively active caspase-3
Horst Dürkop, Burkhard Hirsch, Corinna Hahn, et al.
Leukemia & Lymphoma
|
June 20, 2007
New anti-CD30 human pancreatic ribonuclease-based immunotoxin reveals strong and specific cytotoxicity in vivo
Sandra Braschoss, Burkhard Hirsch, Stefan Dübel, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 12, 2011
Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells
Osamu Suzuki, Burkhard Hirsch, Masafumi Abe, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 3, 2013
RIP1 expression is necessary for CD30-mediated cell death induction in anaplastic large-cell lymphoma cells
Burkhard Hirsch, Edda von der Wall, Michael Hummel, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 4, 2011
Retraction: The IL-15Rα chain signals through association with Syk in human B cells
Thomas Pohl, Hans Krause, Horst Dürkop, et al.
The Journal of Pathology
|
May 20, 2003
Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation
Horst Dürkop, Burkhard Hirsch, Corinna Hahn, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 9, 2007
A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice
Hendrik Fuchs, Christopher Bachran, Tongyu Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 16, 2008
Epstein-Barr virus associated large B-cell cardiac lymphoma with simultaneous manifestation in the forearm
Naser Qedra, Chalid Assaf, Horst Dürkop, et al.
Molecular Oncology
|
July 30, 2017
Targeted dianthin is a powerful toxin to treat pancreatic carcinoma when applied in combination with the glycosylated triterpene SO1861
Cheenu Bhargava, Horst Dürkop, Xiangli Zhao, et al.
Journal of Cancer Research and Clinical Oncology
|
January 13, 2018
Antibody-based delivery of tumor necrosis factor (L19-TNFα) and interleukin-2 (L19-IL2) to tumor-associated blood vessels has potent immunological and anticancer activity in the syngeneic J558L BALB/c myeloma model
Hans D Menssen, Ulf Harnack, Ulrike Erben, et al.
Page
of 3